Perceptive Advisors’s GeneDx Holdings WGS Stock Holding History

Perceptive Advisors’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-151,515	Closed	-$4.39M	–	110
2022 Q3	$4.39M	Hold	151,515	–	–	0.13%	83
2022 Q2	$6.3M	Buy	151,515 +75,757	+100%	+$5.14M	0.2%	75
2022 Q1	$7.67M	Hold	75,758	–	–	0.15%	91
2021 Q4	$11.2M	Hold	75,758	–	–	0.17%	86
2021 Q3	$19M	Buy	75,758 +68,879	+1,001%	+$23.7M	0.28%	69
2021 Q2	$3.18M	Buy	6,879 +3,031	+79%	+$1.3M	0.04%	132
2021 Q1	$1.89M	Buy	+3,848	New	+$2M	0.02%	128

Other funds holding WGS

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Perceptive Advisors's WGS Position: Q4 2022 in Review

Perceptive Advisors sold out of GeneDx Holdings (WGS) in Q4 2022, closing a stake of 151,515 shares — an estimated $4.39M sold.

Perceptive Advisors first reported a position in WGS in Q1 2021 and held it in 7 quarters. The position peaked at $19M in Q3 2021. 86 funds tracked by Wall St. Rank hold WGS as of Q4 2022.

Perceptive Advisors reported no remaining GeneDx Holdings position as of Q4 2022 after selling out during the quarter.
Perceptive Advisors sold 151,515 GeneDx Holdings shares in Q4 2022, an estimated $4.39M.
Perceptive Advisors first reported a position in GeneDx Holdings in Q1 2021 and held it in 7 quarters.
Perceptive Advisors's GeneDx Holdings position peaked at $19M in Q3 2021.
86 funds tracked by Wall St. Rank held GeneDx Holdings as of Q4 2022.

Based on Perceptive Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.